Folate administration decreases oxidative status and blood pressure in postmenopausal women

European Journal of Nutrition

Volumn 54, Issue 3, 2015, Pages 429-435

  Cagnacci, Angelo ^a,b   Cannoletta, Marianna ^a   Xholli, Anjeza ^a   Piacenti, Ilaria ^a   Palma, Federica ^a   Palmieri, Beniamino ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Antioxidant; Blood pressure; Cardiovascular risk; Free radicals; Insulin resistance; Lipid

Indexed keywords

5-METHYLTETRAHYDROFOLATE; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TETRAHYDROFOLIC ACID DERIVATIVE; TRIACYLGLYCEROL;

BLOOD; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; HOMOCYSTEINE; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; OXIDATIVE STRESS; POSTMENOPAUSE; TETRAHYDROFOLATES; TRIGLYCERIDES;

EID: 84939897308     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0726-8     Document Type: Article

References (30)

1. Forman JP, Rimm EB, Stampfer MJ, Curhan GC (2005) Folate intake and the risk of incident hypertension among US women. JAMA 293:320–329
2. Kahleová R, Palyzová D, Zvara K, Zvarová J, Hrach K, Novaková I, Hyánek J, Bendlová B, Kozich V (2002) Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins. Am J Hypertens 15:857–864
3. van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD (2001) Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 21:2072–2079
4. Mangoni AA, Sherwood RA, Swift CG, Jackson SH (2002) Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med 252:497–503
5. Anderson TJ, Sun Y-H, Hubacek J, Hyndman ME, Verma S, Shewchuk L, Scott-Douglas N (2006) Effect of folinic acid on forearm blood flow in patients with end-stage renal disease. Nephrol Dial Transplant 21:1927–1933
6. Cagnacci A, Cannoletta M, Volpe A (2009) High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. Eur J Clin Nutr 63:1266–1268
7. Pravenec M, Kozich V, Krijt J, Sokolová J, Zídek V, Landa V, Simáková M, Mlejnek P, Silhavy J, Oliyarnyk O, Kazdová L, Kurtz TW (2013) Folate deficiency is associated with oxidative stress, increased blood pressure, and insulin resistance in spontaneously hypertensive rats. Am J Hypertens 26:135–140
8. Malinow MR (1994) Homocyst(e)ine and arterial occlusive disease. J Intern Med 236:603–617
9. Loscalzo J (1996) The oxidant stress of hyperhomocyt(e)inemia. J Clin Invest 98:5–7
10. Virdis A, Ghidoni L, Cardinal H, Favilla S, Duranti P, Birindelli R, Magagna A, Bernini G, Salvetti G, Taddei S, Salvetti A (2001) Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocyst(e)nemia in normotensive subjects and essential hypertensive patients. JACC 38:1106–1115
11. Mangoni A, Jackson HD (2002) Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 112:556–565
12. Doshi SN, McDowell IFW, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105:22–26
13. Hirsch S, AM Ronco, Vasquez M, de La Maza MP, Garrido A, Barrera G, Gattas V, Glasinovic A, Leiva L, Bunout D (2004) Hyperhomocysteinemia in healthy young men and elderly men with normal serum folate concentration is not associated with poor vascular reactivity or oxidative stress. J Nutr 134:1832–1835
14. Stroes ESG, van Faassen EE, Yo M, Martasek P, Boer P, Govers R, Rabelink TJ (2000) Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 86:1129–1134
15. Verhaar MC, Stroes E, Rabelink TJ (2002) Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol 22:6–13
16. Das U (2003) Folic acid says NO to vascular diseases. Nutrition 19:686–692
17. Griffith TM, Chaytor AT, Bakker LM, Edwards DH (2005) 5-Methyl tetrahydrofolate and tetrahydrobiopterin can modulate electronically mediated endothelium-dependent vascular relaxation. Proc Natl Acad Sci 102:7008–7013
18. Pavlatou MG, Papastmataki M, Apostolakou F, Papassotiriou I, Tentolouris N (2009) FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus. Metab Clin Exp 58:1657–1662
19. Harris MT, Davis WW, Le N-A, Eggleston B, Austin GE, Moussa M, Brown WV (2007) Free oxygen radicals in whole blood correlate strongly with high sensitivity C-reactive protein. J Clin Lipidol 1:593–598
20. Lorgis L, Zeller M, Dentan G, Sicard P, Richard C, Buffet P, L’Huillier I, Beer JC, Cottin Y, Rochette L, Vergely C (2010) The free oxygen radical test (FORT) to assess circulating oxidative stress in patients with acute myocardial infarction. Atherosclerosis 213:616–621
21. Cagnacci A, Bagni B, Zini A, Cannoletta M, Generali M, Volpe A (2008) Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 42:314–320
22. Cagnacci A, Rovati L, Zanni A, Malmusi S, Facchinetti F, Volpe A (1999) Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. Am J Physiol 276:H1355–H1360
23. Verdecchia P (2000) Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 35:844–851
24. Doshi SB, Agarwal A (2013) The role of oxidative stress in menopause. J Midlife Health 4:140–146
25. Lopez-Ruiz A, Sartori-Valinotti J, Yanes LL, Iliescu R, Reckelhoff JF (2008) Sex differences in control of blood pressure: role of oxidative stress in hypertension in females. Am J Physiol Heart Circ Physiol 295:H466–H474
26. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC (2004) Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 256:308–315
27. Kim M, Paik JK, Kang R, Kim SY, Lee SH, Lee JH (2013) Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight/obese individuals. Metabolism 62:554–560
28. Piconi L, Quagliaro L, Ceriello A (2003) Oxidative stress in diabetes. Clin Chem Lab Med 41:1144–1149
29. Villa P, Perri C, Suriano R, Cucinelli F, Panunzi S, Ranieri M, Mele C, Lanzone A (2005) L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism. J Clin Endocrinol Metab 90:4622–4629
30. Sj Moat, Lang D, McDowel IFW, Clarke ZL, Maldhavan AK, Lewis MJ, Goodfellow J (2004) Folata, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 15:64–79